TCT 843: TricValve procedure in a patient who had already presented with significant RV dysfunction - choosing the ideal moment of intervention.

Within the last 24 months, I have had financial relationship(s) with the ineligible company or companies listed below:

• Consultant Fee/Honoraria/Speaker’s Bureau - Edwards Lifesciences; Abbott; Boston Scientific Corporation; Medtronic